Know Cancer

or
forgot password
  • cancer clinical trials in bethesda, MD

  • Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
    Warren Grant Megnuson Clinical Center – NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892
    Leukemia, Hairy Cell Leukemia, HCL
    Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
    National Institutes of Health
    Bethesda, Maryland 20892
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hypopituitarism, Hypogonadism, Thyroid Dysfunction, Bone Diseases, Metabolic
    Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B
    Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Prostate Cancer
    Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
    Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892
    Leukemia, Non-Hodgkin's Lymphoma, NHL
    Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease, Acute Leukemia, Multiple Myeloma
    Vaccine Therapy in Treating Patients With Breast Cancer
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Breast Cancer
    Evaluation of Albuminuria HIV-Infected Patients
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    HIV-Associated Focal Segmental Glomerulosclerosis, HIV-Associated Collapsing Glomerulopathy, Proteinuria, Albuminuria, Renal Tubular Toxicity
    LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
    1200.22.3 Boehringer Ingelheim Investigational Site
    Bethesda, Maryland
    Carcinoma, Non-Small-Cell Lung
    Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Chronic Lymphocytic Leukemia
    Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    HIV Infections
    Phase II Study of Vandetanib in Individuals With Kidney Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Renal Cancer, Von Hippel Lindau
    The Study of Barrett's Esophagus: What Are the Factors of Progression
    Bethesda Naval Medical Center
    Bethesda, Maryland 20889
    Barrett's Esophagus, Esophageal Neoplasms
    Trial of Enzastaurin and Bevacizumab in Adults With Recurrent Malignant Gliomas
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Recurrent Glioblastoma
    Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Thymoma, Thymic Carcinoma
    Natural History Study of Patients With Neurofibromatosis Type 2
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Spinal Cord Disease, Intracranial Central Nervous System Disorder, Neurologic Disorders, Brain Neoplasms
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Myelodysplastic Syndrome (MDS), Severe Aplastic Anemia (SAA)
    PET Imaging of P-glycoprotein Function Using [11C]dLop
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Healthy
    Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Non-Small Cell Lung Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Oncology Care Associates

    Trial Locations
    Oncology Care Associates
    Carolyn Hendricks, MD
    Breast Cancer
    Montelukast to Treat Bronchiolitis Obliterans
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Bronchiolitis Obliterans, Chronic Graft Versus Host Disease, Leukotriene, Montelukast, Stem Cell Transplant
    A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
    NCI/NIH - Pediatric Oncology Branch
    Bethesda, Maryland 20892
    Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone
    Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Melanoma, Metastatic Renal Cell Cancer, Metastatic Cancer
    Pegintron to Treat Plexiform Neurofibromas in Children and Young Adults
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neurofibromatosis Type 1, Plexiform Neurofibroma
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Non Small Cell Lung Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Sclerotic Graft Versus Host Disease, Imatinib Mesylate
    Establishment of Fibroid Tissue Bank
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Leiomyoma, Fibroids
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    National Naval Medical Center
    Bethesda, Maryland 20889
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Experimental Device to Improve Colonoscopy
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Colonoscopy, Looping, Prevent Looping, Colon Cancer Screening, Segmental Stiffening Wire
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Natural Killer Cells and Bortezomib to Treat Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lung or Prostatic Neoplasms, Colorectal or Kidney Neoplasms, Pancreatic Neoplasms, Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive, Melanoma, CLL
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Renal Cell Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Carcinoma
    An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
    NIH/National Cancer Institute
    Bethesda, Maryland 20892
    Malignant Pleural Mesothelioma
    Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Multiple Myeloma and Plasma Cell Neoplasm
    Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Multiple Myeloma and Plasma Cell Neoplasm
    Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    WAGR Syndrome, Wilm's Tumor, Aniridia, Urogenital Abnormalities, Mental Retardation
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Non-small Cell Lung Cancer
    Analysis of HIV-1 Replication During Antiretroviral Therapy
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    HIV Infection
    18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Trial Locations
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Walter Reed National Medical Center
    Lymphoma
    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pain/Cancer, Pain, Intractable
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Glioblastoma Multiforme
    ABT-888 and Cyclophosphamide in Treating Patients With Solid Tumors or Lymphoma That Did Not Respond to Previous Therapy
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Breast Cancer
    The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cancer, HIV Infections
    Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Metastatic Breast Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Ovarian Cancer